ArticleMedicine2026
Racial disparities in lung cancer mortalities in the United States: A retrospective analysis.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lung cancer is the most commonly diagnosed cancer and leading cause of cancer deaths globally. In the United States, it accounts for about 1 in 8 of all cancer diagnoses. This study examines racial disparities due to lung cancer-related mortality in the United States, focusing on diverse demographic groups. We queried the Centers for Disease Control and Prevention Wide-Ranging Online Data for Epidemiologic Research database for mortality statistics associated with lung and bronchus cancer (international classification of diseases-10 code: C34.0) between the years 1999 and 2020. Age adjusted mortality rates (AAMR) were calculated for various subgroups stratified by race. Joinpoint regression analysis was used to calculate the annual percentage changes and average annual percentage changes in AAMR and assess the temporal trends. During the study period, there were 35,99,330 lung cancer deaths with an AAMR of 61.5 per 1,00,000. Mortality rates in males (AAMR: 78.5) exceeded those in females (AAMR: 48.7) across all racial groups. The highest mortality rate was observed among Non-Hispanic (NH) Black individuals (AAMR: 67.1), while Hispanics had the lowest (AAMR: 25.8). Regionally, the South had the highest mortality rate (AAMR: 66.7), with NH Whites having the highest rate (AAMR: 72.2). The midwest followed (AAMR: 66.6), with highest death rate in NH Blacks (AAMR: 79.5). Rural areas (AAMR: 71.2) had higher rates than urban areas (AAMR: 59.5). Hispanics/Latinos had the lowest age-adjusted mortality rates in all regions. NH Blacks face pronounced disparities in lung cancer mortality, emphasizing the need for targeted interventions in high-risk groups. Understanding regional variations provides insights for tailored strategies to mitigate disparities and reduce lung cancer-related mortality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.